All Submissions
Efficacy & safety of fast-acting insulin aspart are maintained over 52 weeks: comparison with insulin aspart in onset 1
Edward Franek
0 views
0 downloads
Video
PDF
Abstract
0 Datasets
Powered by
Discover more research and events on
morressier.com
Imprint
Terms of Service
Privacy Policy
Accessibility